TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes March 4, 1988
TCL Archive NCI To Slow New Center Development To Assure Funding For Existing Commitments, King Says February 14, 1975
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
